Fig. 1From: Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trialSORAMIC trial design. Indicated in red are the time points chosen for discovery of the variants. SNV, single nucleotide variant; InDel, insertion and deletion; R, randomization; TX, therapy; RFA, radiofrequency ablation; 90Y-RE, 90Y-radioembolizationBack to article page